The 36-month beta value for KPRX is at -0.17. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for KPRX is 23.95M, and currently, shorts hold a 0.21% of that float. The average trading volume for KPRX on April 24, 2024 was 1.66M shares.
KPRX) stock’s latest price update
The stock price of Kiora Pharmaceuticals Inc (NASDAQ: KPRX) has jumped by 19.48 compared to previous close of 0.49. Despite this, the company has seen a gain of 5.40% in its stock price over the last five trading days. Newsfile Corp reported 2024-04-05 that Encinitas, California–(Newsfile Corp. – April 5, 2024) – Kiora Pharmaceuticals (NASDAQ: KPRX) invites investors to view the Company’s online presentations from two upcoming investor conferences. Kiora will present at The 23rd Annual Needham Virtual Healthcare Conference on April 11th, at 10:15 am EDT.
KPRX’s Market Performance
Kiora Pharmaceuticals Inc (KPRX) has seen a 5.40% rise in stock performance for the week, with a -3.42% decline in the past month and a -0.84% plunge in the past quarter. The volatility ratio for the week is 14.37%, and the volatility levels for the past 30 days are at 10.72% for KPRX. The simple moving average for the past 20 days is 0.70% for KPRX’s stock, with a -0.99% simple moving average for the past 200 days.
KPRX Trading at -5.74% from the 50-Day Moving Average
After a stumble in the market that brought KPRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -88.96% of loss for the given period.
Volatility was left at 10.72%, however, over the last 30 days, the volatility rate increased by 14.37%, as shares sank -0.28% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.84% lower at present.
During the last 5 trading sessions, KPRX rose by +5.40%, which changed the moving average for the period of 200-days by -12.88% in comparison to the 20-day moving average, which settled at $0.5754. In addition, Kiora Pharmaceuticals Inc saw 10.93% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for KPRX
The total capital return value is set at -1.03. Equity return is now at value -142.88, with -77.27 for asset returns.
Based on Kiora Pharmaceuticals Inc (KPRX), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -89.41. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is 258.89.
Currently, EBITDA for the company is -8.63 million with net debt to EBITDA at 0.48. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.90.
Conclusion
In conclusion, Kiora Pharmaceuticals Inc (KPRX) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
